Table 11.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1992 to 2001

Recipients with Heart Transplants

		Year of Transplant
		1992	1993	1994	1995	1996	1997	1998	1999	2000	2001
Transplants		2,171	2,298	2,340	2,362	2,343	2,294	2,348	2,188	2,197	2,202
Tx With Follow-up Immunosuppression Info		1,832	1,913	1,918	1,912	1,931	1,885	1,963	1,766	1,800	1,819
Corticosteroids	Category Usage	95.7%	95.9%	90.3%	90.8%	89.0%	87.7%	90.3%	93.0%	92.7%	91.1%
	Steroids	95.7%	95.9%	90.3%	90.8%	89.0%	87.7%	90.3%	93.0%	92.7%	91.1%
Cyclosporine	Category Usage	99.0%	98.2%	89.5%	82.3%	85.0%	82.9%	78.5%	81.3%	77.1%	64.9%
	Cyclosporin	98.9%	96.9%	81.7%	1.6%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	0.7%	3.6%	7.8%	42.9%	19.5%	12.3%	10.4%	7.9%	5.4%	3.4%
	Neoral	0.1%	0.3%	0.8%	42.0%	66.3%	71.4%	68.6%	73.8%	68.3%	52.1%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	5.2%	11.4%
	Eon	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.7%
Tacrolimus	Category Usage	1.1%	1.8%	3.5%	10.1%	15.2%	17.8%	24.6%	27.3%	30.7%	42.9%
	FK506	1.1%	1.8%	3.5%	10.1%	15.2%	17.8%	24.6%	27.3%	30.7%	42.9%
Antimetabolites	Category Usage	96.5%	95.6%	89.8%	88.2%	90.3%	90.1%	90.4%	86.5%	91.0%	89.1%
	Azathioprine	96.5%	95.0%	87.9%	76.3%	62.0%	42.7%	34.4%	28.7%	18.9%	14.7%
	Mycophenolate mofetil	0.2%	0.6%	2.9%	16.8%	32.4%	51.4%	64.3%	66.9%	79.0%	80.5%
Other	Category Usage	2.0%	1.8%	1.8%	2.0%	1.1%	1.1%	1.3%	2.8%	5.2%	7.8%
	Rapamycin	0.0%	0.0%	0.1%	0.0%	0.0%	0.2%	0.4%	2.2%	4.7%	7.5%
	Cytoxan	2.0%	1.8%	1.7%	2.0%	1.1%	0.9%	1.0%	0.7%	0.7%	0.2%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.